1-3
2026
影响因子区间
—
平台估算
8%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:The Journal of Hematopathology aims at providing pathologists with a special interest in hematopathology with all the information needed to perform modern pathology in evaluating lymphoid tissues and bone marrow. To this end the journal publishes reviews, editorials, comments, original papers, guidelines and protocols, papers on ancillary techniques, and occasional case reports in the fields of the pathology, molecular biology, and clinical features of diseases of the hematopoietic system.The journal is the unique reference point for all pathologists with an interest in hematopathology. Molecular biologists involved in the expanding field of molecular diagnostics and research on lymphomas and leukemia benefit from the journal, too. Furthermore, the journal is of major interest for hematologists dealing with patients suffering from lymphomas, leukemias, and other diseases.The journal is unique in its true international character. Especially in the field of hematopathology it is clear that there are huge geographical variations in incidence of diseases. This is not only locally relevant, but due to globalization, relevant for all those involved in the management of patients.
【译文】《血液病理学杂志》旨在为对血液病理学有特殊兴趣的病理学家提供所有必要的信息,以进行现代病理学评估淋巴组织和骨髓。为此,该杂志发表评论、社论、评论、原创论文、指南和方案、辅助技术论文以及偶尔的病例报告,涉及病理学、分子生物学和造血系统疾病临床特征领域。该杂志是所有对血液病理学感兴趣的病理学家的独特参考点。从事分子诊断和淋巴瘤、白血病研究的分子生物学家也能从该杂志中受益。此外,对于处理患有淋巴瘤、白血病和其他疾病患者的血液学家来说,该杂志也具有重要意义。该杂志在国际上具有独特的性质。特别是在血液病理学领域,疾病的发病率存在巨大的地理差异。这不仅与当地相关,而且由于全球化,对所有参与患者管理的人来说都具有重要意义。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q4 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |